XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash flows from operating activities:    
Net loss $ (18,374,354) $ (8,637,316)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation expense 51,956 42,213
Stock-based compensation expense 813,499 650,895
Changes in assets and liabilities:    
Grant funds receivable (0) (49,006)
Prepaid expenses and other current assets 707,084 1,251,539
Other assets (986,498) 2,173,276
Accounts payable and accrued expenses 2,333,791 (645,955)
Total adjustments 3,478,660 (3,328,656)
Net cash used in operating activities (14,895,694) (11,965,972)
Cash flows from investing activities:    
Purchase of equipment 29,997 134,258
Net cash used in investing activities (29,997) (134,258)
Cash flows from financing activities:    
Net proceeds from sale of common stock and warrants 0 27,727,194
Net proceeds from warrant exercise 0 7,626,134
Net cash provided by financing activities 0 35,353,328
Net increase (decrease) in cash and cash equivalents (14,925,691) 23,253,098
Cash and cash equivalents at beginning of period 27,612,732 11,423,870
Cash and cash equivalents at end of period $ 12,687,041 $ 34,676,968